Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery
Stopped Less patients than expected for inclusion, therefore recruitment is too low
Conditions
- Anemia
- Orthopedic Surgery
- High Risk of Blood Loss
Interventions
- DRUG: Ferinject 50 mg/ml
- DRUG: NaCl 0.9%
Sponsor
University Hospital Muenster
Collaborators